• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PYC 4.17% 11.5¢

PYC THERAPEUTICS LIMITED

PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company... PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company creating a new generation of ribonucleic acid (RNA) therapies to change the lives of patients with genetic diseases. The Company utilizes its proprietary drug delivery platform to enhance the potency of precision medicines within the rapidly growing and commercially proven RNA therapeutic class. Its drug development programs target monogenic diseases - the indications with the highest likelihood of success in clinical development. Its first-in-class drug programs include Retinitis Pigmentosa type 11, (VP-001), Polycystic Kidney Disease, (PYC-003), Autosomal Dominant Optic Atrophy (ADOA) (PYC-001) and Phelan-McDermid Syndrome (PMS) (PYC-002). The Company's VP-001 program is a lead asset for a blinding eye disease of childhood progressed through multiple patient cohorts in the ongoing single ascending dose clinical trial. ADOA is a progressive and blinding eye disease.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PYC
FDA orphan designation
26/05/24 14 5.4K
26/05/24 Last post  travelbug2 Comments Created with Sketch.  14  Views Created with Sketch.  5.4K 
PYC
News clipping
25/05/24 0 403
25/05/24 Last post  ralom Comments Created with Sketch.  0  Views Created with Sketch.  403 
PYC 24/05/24 0 314
TRENDING NEWS

Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market

NEWS
27 May 2024
24/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  314 
PYC
News: PYC PYC Therapeutics Says US FDA Grants Orphan Drug Designation To PYC Drug Candidate
24/05/24 0 173
24/05/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  173 
PYC 24/05/24 2 823
24/05/24 Last post  actionnaire Comments Created with Sketch.  2  Views Created with Sketch.  823 
PYC
PYC Chart and Technical Analysis
2 3
23/05/24 143 61K
23/05/24 Last post  travelbug2 Comments Created with Sketch.  143  Views Created with Sketch.  61K 
PYC 23/05/24 0 337
23/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  337 
PYC 23/05/24 0 242
23/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  242 

See All Discussions arrow Created with Sketch.

Timeline

US FDA Grants Orphan Drug Designation to PYC Drug Candidate
24 May 09:44
 
Small Shareholdings Sale Facility
24 May 08:22
 
Issue of Options
23 May 17:18
 
Notification regarding unquoted securities - PYC
23 May 17:15
 
Change in substantial holding
17 May 14:03
 
Change of Director's Interest Notice
17 May 14:02
 
View More arrow Created with Sketch.
(20min delay)
Last
11.5¢
Change
-0.005(4.17%)
Mkt cap ! $536.6M
Open High Low Value Volume
11.5¢ 12.0¢ 11.5¢ $298.9K 2.596M

Buyers (Bids)

No. Vol. Price($)
18 431005 11.0¢
 

Sellers (Offers)

Price($) Vol. No.
11.5¢ 387729 7
View Market Depth
Last trade - 13.21pm 27/05/2024 (20 minute delay) ?
Last
11.5¢
  Change
-0.005 ( 0.00 %)
Open High Low Volume
12.0¢ 12.0¢ 11.0¢ 966690
Last updated 13.40pm 27/05/2024 ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.